Abivax Sa's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Abivax Sa's ROA in the fourth quarter of 2025?
Abivax Sa recorded a cumulative net loss of $-380 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -55.65%.

However, within the Healthcare sector 677 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 4671.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Total Assets Change	184.73 %	234.03 %	184.73 %	184.73 %	-37.25 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-380	-331	-212	-199	-191
Return On Assets (TTM)	-55.65 %	-57.4 %	-48.06 %	-59.32 %	-82.96 %
ABVX's Total Ranking	# 4671	#	#	#	# 5135
Total Assets (TTM) in million	654	768	654	654	230
Seq. Total Assets Change	-14.76 %	17.32 %	0 %	184.73 %	0 %
Seq. Net Income Change	-	-	-	-	-

ABVX's 5 Years Annual ROA >> Back to ABVX Management Effectiveness >> Compare ABVX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 300
Sector	# 678
Overall	# 4630

Return On Assets Statistics
High	Average	Low
-57.52 %	-71.7 %	-85.88 %
(Dec 31 2025)		(Dec 31 2024)

Financial Statements
Abivax Sa's Assets	$ 654 million	ABVX's Balance sheet
Abivax Sa's Income	$ -91 million	Quarterly ABVX's Income Statement
ABVX's Income by Division		See ABVX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	FY	FY
Y / Y Total Assets Change	184.73 %	-37.25 %	-	-	-
Total Assets in million	654	230	366	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-376	-197	-165	0	0
Annual Return On Assets	-57.52 %	-85.88 %	-45.17 %	-	-

ABVX's 5 Years Annual ROA >> Back to ABVX Management Effectiveness >> Compare ABVX ROA to its Competitors

More Return On Assets Ratios
ABVX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ABVX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ABVX's Competitors
Subscribers only: Roa for Abivax Sa's Suppliers
Subscribers only: Return On Assets for ABVX's Customers

You may also want to know
ABVX's Roi	ABVX's Inventory Turnover Ratio	ABVX's Growth Rates	ABVX's Dividend Comparisons
	ABVX's Profitability Ratios	ABVX's Asset Turnover Ratio	ABVX's Dividend Growth
ABVX's Roe	ABVX's Valuation Ratios	ABVX's Financial Strength Ratios	ABVX's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:31:11+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.